EMCDDA Document Library

This report presents an overview of the drug phenomenon in Luxembourg, covering drug policy, drug supply and demand, drug use patterns, health consequences and responses, as well as drug markets and crime. The statistical data and analysis presented in this report relate to 2019 or the most recent...

This knowledge questionnaire has been developed by the EMCDDA as part of its initiative to increase access to hepatitis C care through drug services. The main aims of the knowledge questionnaire are: to refresh knowledge on hepatitis C virus (HCV) and hepatitis B virus (HBV) transmission, testing...

COVID-19 guidance published by the UNODC for people who use drugs and people in prison. Publisher's summary: All people have the right to health, even in countries under lockdown or where a state of emergency has been declared. This includes access to life-saving HIV harm reduction services and...

Hepatitis C virus (HCV) infection has a high prevalence in people who inject drugs (PWID) in Europe, although HCV infection is both preventable and curable. Effective interventions that target the prevention of HCV transmission and the treatment of hepatitis C are needed, particularly for so‐called...